Leukoplakia: An Invasive Cancer Hidden within the Vocal Folds. A Multivariate Analysis of Risk Factors.
anterior commissure (AC)
glottic cancer
narrow band imaging (NBI)
vocal fold leukoplakia
white light
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
09
2021
accepted:
22
11
2021
entrez:
30
12
2021
pubmed:
31
12
2021
medline:
31
12
2021
Statut:
epublish
Résumé
Discerning the preoperative nature of vocal fold leukoplakia (VFL) with a substantial degree of certainty is fundamental, seeing that the histological diagnosis of VFL includes a wide spectrum of pathology and there is no consensus on an appropriate treatment strategy or frequency of surveillance. The goal of our study was to establish a clear schedule of the diagnostics and decision-making in which the timing and necessity of surgical intervention are crucial to not miss this cancer hidden underneath the white plaque. We define a schedule as a combination of procedures (white light and Narrow Band Imaging diagnostic tools), methods of evaluating the results (a combination of multiple image classifications in white light and Narrow Band Imaging), and taking into account patient-related risk factors, precise lesion location, and morphology. A total number of 259 patients with 296 vocal folds affected by leukoplakia were enrolled in the study. All patients were assessed for three classifications, in detail according to Ni 2019 and ELS 2015 for Narrow Band Imaging and according to Chen 2019 for white light. In 41 of the 296 folds (13.9%), the VFL specimens in the final histology revealed invasive cancer. We compared the results from the classifications to the final histology results. The results showed that the classifications and evaluations of the involvement of anterior commissure improve the clinical utility of these classifications and showed improved diagnostic performance. The AUC of this model was the highest (0.973) with the highest sensitivity, specificity, PPV, and NPV (90.2%, 89%, 56.9%, and 98.3%, respectively). The schedule that combines white light and Narrow Band Imaging, with a combination of the two classifications, improves the specificity and predictive value, especially of anterior commissure involvement.
Identifiants
pubmed: 34966677
doi: 10.3389/fonc.2021.772255
pmc: PMC8711120
doi:
Types de publication
Journal Article
Langues
eng
Pagination
772255Informations de copyright
Copyright © 2021 Klimza, Pietruszewska, Rosiak, Morawska, Nogal and Wierzbicka.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Ann Otol Rhinol Laryngol. 1996 Apr;105(4):303-8
pubmed: 8604894
Clin Otolaryngol. 2010 Jun;35(3):170-6
pubmed: 20636735
Head Neck. 2016 Jan;38(1):15-20
pubmed: 24995546
Ann Otol Rhinol Laryngol. 2008 Jan;117(1):74-9
pubmed: 18254375
Am J Otolaryngol. 2021 May-Jun;42(3):102904
pubmed: 33460979
Clin Otolaryngol. 2019 Sep;44(5):729-735
pubmed: 31074935
Ear Nose Throat J. 2020 Nov 20;:145561320973770
pubmed: 33213196
Head Neck. 2012 Nov;34(11):1574-9
pubmed: 22290602
Laryngoscope. 2019 Feb;129(2):429-434
pubmed: 30229933
PLoS One. 2017 Jun 29;12(6):e0180590
pubmed: 28662209
Head Neck. 2016 Apr;38 Suppl 1:E1998-2003
pubmed: 26849206
Laryngoscope. 2015 Jul;125(7):1600-6
pubmed: 25582112
Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2485-2492
pubmed: 32350646
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 May;49(5):368-73
pubmed: 25017219
Ear Nose Throat J. 2021 Dec;100(10):737-741
pubmed: 32383982
Braz J Otorhinolaryngol. 2019 Sep - Oct;85(5):588-596
pubmed: 30166121
Cancers (Basel). 2021 Jun 30;13(13):
pubmed: 34208811
Eur Arch Otorhinolaryngol. 2016 May;273(5):1207-14
pubmed: 26677852
Medicine (Baltimore). 2017 Jun;96(22):e7033
pubmed: 28562558
Eur Arch Otorhinolaryngol. 2018 Jan;275(1):147-151
pubmed: 29086006
Eur Arch Otorhinolaryngol. 2017 Jan;274(1):355-359
pubmed: 27515705
Acta Otolaryngol. 1981 Jul-Aug;92(1-2):167-71
pubmed: 7315249
Laryngoscope. 2015 Feb;125(2):E62-6
pubmed: 25125245
Eur Arch Otorhinolaryngol. 2020 Jun;277(6):1715-1723
pubmed: 32112142
Curr Opin Otolaryngol Head Neck Surg. 2012 Dec;20(6):472-6
pubmed: 23000733
Head Neck Pathol. 2017 Mar;11(1):23-32
pubmed: 28247231
Expert Rev Anticancer Ther. 2013 Sep;13(9):1045-51
pubmed: 24053203
Laryngoscope. 2020 Jun;130(6):1362-1363
pubmed: 32034947
Int J Oral Maxillofac Surg. 2010 Mar;39(3):208-13
pubmed: 20185271
Ann Otol Rhinol Laryngol. 1989 Feb;98(2):105-9
pubmed: 2916820
Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1819-1825
pubmed: 29713886
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):313-8
pubmed: 25654369
Head Neck. 2015 Feb;37(2):215-22
pubmed: 24375619
Surg Radiol Anat. 2017 Aug;39(8):871-876
pubmed: 28405749
Biom J. 2005 Aug;47(4):458-72
pubmed: 16161804
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2397-2409
pubmed: 33710441
J Laryngol Otol. 2011 Mar;125(3):288-96
pubmed: 21054921